Chronic obstructive pulmonary disease (COPD), an established risk factor for lung cancer,
remains largely undiagnosed and untreated before lung cancer surgery. We evaluated the …

Purpose Long-acting bronchodilators are recommended as a first-line treatment for chronic
obstructive pulmonary disease (COPD), although their effects for postoperative lung cancer …

Purpose: The purpose of our study was to determine the incidence of various types of
postoperative pulmonary complications and to evaluate the impact of chronic obstructive …

OBJECTIVES: Recent data have suggested that there is a flexibility of borderline values of
lung function tests in allowing safe lung resection. The aim of this study was to assess the …

Chronic obstructive pulmonary disease (COPD) increases postoperative morbidity and is
associated with diminished long-term survival after lung cancer resection. Whether this is …

Objective The purpose was to determine the rates of postoperative pulmonary
complications, and to clarify the impact of COPD on long-term survival in lung cancer …

BACKGROUND: The aim of this study was to evaluate the influence of chronic obstructive
pulmonary diseases (COPD) on postoperative pulmonary function and to elucidate the …

Purpose This study aimed to investigate whether the prevalence of postoperative pulmonary
complications (PPCs) in patients with non-small-cell lung cancer (NSCLC) is even higher in …

Objective This study aimed to investigate whether perioperative inhalations of long-acting
beta-agonists (LABAs) or long-acting muscarinic antagonists (LAMAs) might decrease the …

Background Lung cancer is the first cause of cancer mortality worldwide. Chronic obstructive
pulmonary disease (COPD) is an independent risk factor for lung cancer. An …